Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors
John Wiley & Sons Inc, 2006
221,25 €On orderDelivery: 2-3 weeks
GSK-3 is a promising drug target that has been extensively tested, and shown great potential for treatment of diseases that have no current effective treatment - like Alzheimer's, bipolar disorder, and cancer.
- ISBN-13
- 9780471770015
- ISBN-10
- 0471770019
- Publisher
- John Wiley & Sons Inc
- Year
- 2006
- Publication date
- 2006-11-03
- Pages
- 384
- Dimensions
- 243x161x24
- Weight
- 658